Eight-year results after aortic valve replacement with the CryoLife-O’Brien Stentless Aortic Porcine Bioprosthesis Ivo Martinovic, MD, Ibrahim Farah,

Slides:

Advertisements

Similar presentations

W. R. Eric Jamieson, MD, Clifton T. P. Lewis, MD, Marc P

Advertisements

Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: Summary assessment of.

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Of mice and men and surgical transcatheter aortic valve insertion

Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters Victor Dayan, MD, PhD, Philippe Pibarot,

Influence of the On-X mechanical prosthesis on intermediate-term major thromboembolism and hemorrhage: A prospective multicenter study Vincent Chan,

Aborted episode of sudden death due to delayed heart block after transcatheter aortic valve insertion Kevin L. Greason, MD, Paul A. Friedman, MD, Daniel.

Lars G. Svensson, MD, PhD, Eugene H. Blackstone, MD

Sergey Leontyev, MD, Michael A

Lars G. Svensson, MD, PhD, Lillian H. Batizy, MS, Eugene H

In which patients is transcatheter aortic valve replacement potentially better indicated than surgery for redo aortic valve disease? Long-term results.

Long-term prognosis of ascending aortic aneurysm after aortic valve replacement for bicuspid versus tricuspid aortic valve stenosis Evaldas Girdauskas,

Prospective randomized comparison of CarboMedics and St

Bigger valve size is not always better

Surgical treatment of pseudoaneurysm of the thoracic aorta

Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: Changes in risks, valve types, and outcomes in the Society.

Association between indices of prosthesis internal orifice size and operative mortality after isolated aortic valve replacement Charles R. Bridges, MD,

Long-term follow-up after aortic valve replacement with Edwards Prima Plus stentless bioprostheses in patients younger than 60 years of age Torsten Christ,

Aortic root remodeling leads to good valve stability in acute aortic dissection and preexistent root dilatation Takashi Kunihara, MD, PhD, Niklas Neumann,

Neurologic complications after off-pump coronary artery bypass grafting with and without aortic manipulation: Meta-analysis of 11,398 cases from 8 studies

Bicuspid aortic valve aortopathy: One size fits all?

Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement Ole Lund, MD, PhD, Martin Bland,

The lord of the rings Antonio Miceli, MD, PhD

A new paradigm for obtaining marketing approval for pediatric-sized prosthetic heart valves Ajit P. Yoganathan, PhD, Mark Fogel, MD, Susan Gamble, BS,

The variability of the mitral valve anatomy and terminology

Does the degree of preoperative mitral regurgitation predict survival or the need for mitral valve repair or replacement in patients with anomalous origin.

Long-term evaluation of biological versus mechanical prosthesis use at reoperative aortic valve replacement Vincent Chan, MD, MPH, B-Khanh Lam, MD, MPH,

Nationwide cohort study of mitral valve repair versus replacement for infective endocarditis Hsiu-An Lee, MD, Yu-Ting Cheng, MD, Victor Chien-Chia Wu,

W. R. Eric Jamieson, MD, Clifton T. P. Lewis, MD, Marc P

Transcatheter aortic valve replacement in intermediate-risk patients

Innovation and science: The future of valve design

Aortic valve replacement with the Mitroflow pericardial bioprosthesis: Durability results up to 21 years Charles A. Yankah, MD, PhD, Miralem Pasic, MD,

Michele Gallo, MD, Gino Gerosa, MD

Military surgeons just want to have fun

Stentless biological valved conduit for aortic root replacement: Initial experience with the Shelhigh BioConduit model NR-2000C Abdullah Kaya, MD, Robin.

Joshua M. Rosenblum, MD, PhD, Bradley G. Leshnower, MD, Rena C

Transcatheter aortic valve replacement and surgical aortic valve replacement: Both excellent therapies J. James Edelman, MBBS(Hons), PhD, Vinod H. Thourani,

Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005 Scott D. Barnett, PhD,

Vivek Rao, MD, PhD, Carolyn M. David, BN

Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Niv Ad, MD, Lawrence M. Wei, MD

Replicating the success of mitral valve repair in the aortic valve

Thirty-year experience with a bileaflet mechanical valve prosthesis

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Sutureless valve implantation: Every detail counts

Biomaterials for heart valve replacement: Conjectures and refutations

Hans-Joachim Schäfers, MD

Concomitant replacement of the ascending aorta is free—for some

Siva Raja, MD, PhD, Jay J. Idrees, MD, Eugene H

Quality of life after aortic valve surgery: Replacement versus reconstruction Diana Aicher, MD, Annika Holz, Susanne Feldner, MD, Volker Köllner, MD,

Long-term results of Freestyle stentless bioprosthesis in the aortic position: A single- center prospective cohort of 500 patients Nicolas Amabile, MD,

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

The future of cardiac surgery training: A survival guide

Permanent pacemaker insertion following transcatheter aortic valve replacement: Not infrequent, not benign, and becoming predictable Craig M. Jarrett,

The continuing challenge of congenital heart disease in China

Commentary: When a choice is not an echo

Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement Todd M. Dewey,

YingXing Wu, MD, Gary L. Grunkemeier, PhD, Albert Starr, MD

“The more things change…”: The challenges ahead

Toward a more rational approach in treating type B aortic dissection

Preoperative PFTs: The answer is blowing in the wind

National trends in utilization and in-hospital outcomes of mechanical versus bioprosthetic aortic valve replacements Abby J. Isaacs, MS, Jeffrey Shuhaiber,

Did you like Terminator 3 better than Terminator 2

Transcatheter aortic valve implantation versus surgical aortic valve replacement: A propensity score analysis in patients at high surgical risk Lenard.

Which biologic valve should we select for the 45- to 65-year-old age group requiring aortic valve replacement? F. Dagenais, MD, P. Cartier, MD, P. Voisine,

Lessons learned from Melody valve retrieved at transplantation

Zone zero thoracic endovascular aortic repair is all about “location, location, location” Kevin L. Greason, MD The Journal of Thoracic and Cardiovascular.

Paul Philipp Heinisch, MD, Thierry Carrel, MD

Presentation transcript:

Eight-year results after aortic valve replacement with the CryoLife-O’Brien Stentless Aortic Porcine Bioprosthesis Ivo Martinovic, MD, Ibrahim Farah, MD, Manfred Everlien, MD, Stephan Lindemann, MD, Igor Knez, MD, Thomas Wittlinger, MD, Hans Greve, MD, PhD, Paul Vogt, MD, PhD The Journal of Thoracic and Cardiovascular Surgery Volume 130, Issue 3, Pages 777.e1-777.e7 (September 2005) DOI: 10.1016/j.jtcvs.2005.05.011 Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Freedom from death after AVR. Open circles represent estimated survival for 73-year olds in Germany in 2001. Data are from National Statistics Bureau (Statistisches Bundesamt) Wiesbaden, 2004. Vertical line represents 95% confidence interval of survival for patients with CryoLife-O’Brien valves; n indicates number of patients at risk for each interval. The Journal of Thoracic and Cardiovascular Surgery 2005 130, 777.e1-777.e7DOI: (10.1016/j.jtcvs.2005.05.011) Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Freedom from cardiac death; n indicates number of patients at risk for each interval. The Journal of Thoracic and Cardiovascular Surgery 2005 130, 777.e1-777.e7DOI: (10.1016/j.jtcvs.2005.05.011) Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Freedoms from valve-related events of endocarditis (filled circles) and thromboembolic events (open diamonds); n indicates number of patients at risk for each interval. The Journal of Thoracic and Cardiovascular Surgery 2005 130, 777.e1-777.e7DOI: (10.1016/j.jtcvs.2005.05.011) Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions